This article provides an alternative conception of postconventional moral development which fits existing data on late adolescent and adult moral judgment better than Kohlberg’s higher stage descriptions. Moral judgment data from a longitudinal study of 26 undergraduates are scored by Kohlberg’s newly revised manual and replicate his original finding that a significant percentage of subjects appear to regress from adolescence to adulthood. The persistence of relativistic regression in these data suggests the need to revise the theory. The same hypothetical moral dilemmas are also scored according to an alternative coding scheme based on the hypothesis of an adult form of cognitive development. Results indicate that the Kohlberg regressors are progressors when evaluated against a standard of commitment in relativism instead of absolute principles of justice. Real-life data on the same subjects suggest that this progression is related to actual experiences of moral conflict and choice which lead to the restructuring of moral judgment to a more dialectical mode. It is suggested that this alternative notion of postconventional development is necessary for understanding (and scoring) adult moral judgment.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.